sec filing
QT
NASDAQ · QTTB
Q32 Bio Inc.
Healthcare · Biotechnology
$10.54
Down-$0.32 (-2.95%)
Updated Sep 20, 2026, 1:19 AM
SID Score
4.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 39.25M
- P/E ratio
- -0.93
- Dividend yield
- 0.00%
- 52-week range
- $4.40 – $23.57
- Volume
- 969.01K
- Avg. volume
- 3.07M
Price performance
QTTB price history
1M range · 19 trading sessions · Daily adjusted prices
QTTB closed at $10.54 after 19 trading sessions, down 35.57% for the selected period.
- Last close
- $10.54
- Period change
- -35.57%
- Period low
- $10.54
- Period high
- $16.36
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $10.84 | $10.97 | $10.46 | $10.54 | 969.01K |
| Sep 17, 2026 | $11.14 | $11.165 | $10.69 | $10.86 | 384.01K |
| Sep 16, 2026 | $11.17 | $11.4124 | $10.87 | $10.98 | 505K |
| Sep 15, 2026 | $10.77 | $11.29 | $10.51 | $11.17 | 602.6K |
| Sep 14, 2026 | $10.96 | $11.28 | $10.63 | $10.91 | 870.61K |
| Sep 11, 2026 | $10.82 | $11.27 | $10.45 | $11.10 | 1.82M |
| Sep 10, 2026 | $11.00 | $11.08 | $10.54 | $10.72 | 937.78K |
| Sep 9, 2026 | $11.61 | $11.95 | $11.065 | $11.14 | 488.86K |
| Sep 8, 2026 | $12.00 | $12.00 | $11.5659 | $11.69 | 592.92K |
| Sep 4, 2026 | $12.60 | $12.70 | $11.50 | $11.99 | 853.81K |
| Sep 3, 2026 | $13.52 | $13.59 | $12.74 | $12.80 | 491.58K |
| Sep 2, 2026 | $14.42 | $14.55 | $13.35 | $13.59 | 434.82K |
| Sep 1, 2026 | $14.77 | $14.77 | $14.18 | $14.36 | 331.61K |
| Aug 31, 2026 | $14.85 | $15.32 | $14.75 | $14.87 | 349.85K |
| Aug 28, 2026 | $15.91 | $16.25 | $14.92 | $15.03 | 353.91K |
| Aug 27, 2026 | $16.08 | $16.30 | $15.93 | $16.15 | 203.36K |
| Aug 26, 2026 | $16.13 | $16.52 | $15.8001 | $16.18 | 327.15K |
| Aug 25, 2026 | $16.36 | $16.98 | $16.06 | $16.32 | 599.09K |
| Aug 24, 2026 | $16.50 | $16.66 | $15.50 | $16.36 | 691.06K |
Latest QTTB news
The latest Smart Investors Daily articles mentioning QTTB.
Stock researchMarket Activity · Options
Loading stock research…